Related Experiment Video
Updated: Sep 3, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
XIST sponges miR-320d to promote chordoma progression by regulating ARF6
Yonggang Wang1, Zhouzhou Tang2, Weichun Guo1
1Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
Background:
Long non-coding RNAs (lncRNAs) have been demonstrated to play important roles in various tumors, including chordoma. The purpose of this study was to investigate the role and mechanism of lncRNA X-inactive specific transcript (XIST) in chordoma.
Methods:
RNA levels and protein levels were measured by real-time quantitative polymerase chain reaction (RT‑qPCR) and western blot assay, respectively. Cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, 5-ethynyl-2'-deoxyuridine (EdU) assay and colony formation assay. Tanswell assay was used to examine cell migration and invasion. Cellular glycolysis was examined via the measurement of extracellular acidification rate (ECAR) and lactate production. The interaction between microRNA-320d (miR-320d) and XIST or ADP-ribosylation factor 6 (ARF6) was predicted by bioinformatics analysis and verified by a dual-luciferase reporter and RNA-pull down assays. The xenograft tumor model was used to explore the biological function of XIST in vivo.
Results:
XIST was overexpressed in chordoma tissues. XIST knockdown suppressed chordoma cell proliferation, migration, invasion, and glycolysis. XIST acted as a sponge of miR-320d. Moreover, miR-320d overexpression inhibited the proliferation, migration, invasion, and glycolysis of chordoma cells. ARF6 was a direct target of miR-320d, and XIST upregulated ARF6 expression via sponging miR-320d. Furthermore, overexpression of ARF6 reversed the inhibitory effects of XIST knockdown on chordoma cell proliferation, migration, invasion, and glycolysis. Importantly, XIST silencing blocked xenograft tumor growth in vivo.
Conclusion:
XIST knockdown inhibited chordoma progression via regulating the miR-320d/ARF6 axis, providing a novel insight into chordoma pathogenesis.
Insights
Long non-coding RNA XIST promotes chordoma progression by enhancing cell proliferation, migration, invasion, and glycolysis. Silencing XIST inhibits tumor growth by regulating the microRNA-320d/ADP-ribosylation factor 6 pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are implicated in various cancers, including chordoma.
- The specific role of lncRNA X-inactive specific transcript (XIST) in chordoma remains to be fully elucidated.
Purpose of the Study:
- To investigate the function and mechanism of lncRNA XIST in chordoma.
- To explore the potential of XIST as a therapeutic target for chordoma.
Main Methods:
- Quantitative real-time PCR and western blot for RNA and protein expression.
- Cell proliferation, migration, invasion, and glycolysis assays (MTT, EdU, colony formation, Transwell, ECAR, lactate production).
- Bioinformatics, dual-luciferase reporter, and RNA-pull down assays to confirm interactions; xenograft model for in vivo validation.
Main Results:
- XIST was overexpressed in chordoma tissues and promoted chordoma cell proliferation, migration, invasion, and glycolysis.
- XIST functioned as a molecular sponge for microRNA-320d (miR-320d), upregulating ADP-ribosylation factor 6 (ARF6) expression.
- XIST knockdown inhibited tumor growth in vivo, while ARF6 overexpression reversed these inhibitory effects.
Conclusions:
- XIST knockdown inhibits chordoma progression by regulating the miR-320d/ARF6 axis.
- This study provides novel insights into chordoma pathogenesis and suggests XIST as a potential therapeutic target.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
Mesenchymal Stem Cells
Cancer Cell Migration through Invadopodia

